Nothing Special   »   [go: up one dir, main page]

DK1009380T3 - Fremgangsmåde til fremstilling af farmaceutiske formuleringer - Google Patents

Fremgangsmåde til fremstilling af farmaceutiske formuleringer

Info

Publication number
DK1009380T3
DK1009380T3 DK98940460T DK98940460T DK1009380T3 DK 1009380 T3 DK1009380 T3 DK 1009380T3 DK 98940460 T DK98940460 T DK 98940460T DK 98940460 T DK98940460 T DK 98940460T DK 1009380 T3 DK1009380 T3 DK 1009380T3
Authority
DK
Denmark
Prior art keywords
formulation
pharmacologically
acceptable
preparation
administration
Prior art date
Application number
DK98940460T
Other languages
English (en)
Inventor
Leburu Seshagiri Rao
Original Assignee
Chauvin Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chauvin Pharmaceuticals Ltd filed Critical Chauvin Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1009380T3 publication Critical patent/DK1009380T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK98940460T 1997-09-03 1998-09-02 Fremgangsmåde til fremstilling af farmaceutiske formuleringer DK1009380T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718568.0A GB9718568D0 (en) 1997-09-03 1997-09-03 Compositions
PCT/GB1998/002637 WO1999011239A1 (en) 1997-09-03 1998-09-02 Method for preparing pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK1009380T3 true DK1009380T3 (da) 2003-02-24

Family

ID=10818388

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98940460T DK1009380T3 (da) 1997-09-03 1998-09-02 Fremgangsmåde til fremstilling af farmaceutiske formuleringer

Country Status (11)

Country Link
US (1) US6379692B1 (da)
EP (1) EP1009380B1 (da)
JP (1) JPH11228386A (da)
AT (1) ATE226428T1 (da)
AU (1) AU741609B2 (da)
CA (1) CA2301325A1 (da)
DE (1) DE69808938T2 (da)
DK (1) DK1009380T3 (da)
ES (1) ES2186207T3 (da)
GB (2) GB9718568D0 (da)
WO (1) WO1999011239A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2396598T3 (es) 2000-08-25 2013-02-22 Senju Pharmaceutical Co., Ltd. Preparaciones en forma de suspensiones acuosas
WO2002026234A1 (fr) * 2000-09-29 2002-04-04 Wakamoto Pharmaceutical Co., Ltd. Gouttes ophtalmiques contenant une suspension d'aciclovir
US20040105889A1 (en) * 2002-12-03 2004-06-03 Elan Pharma International Limited Low viscosity liquid dosage forms
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
EP1499361B1 (en) * 2002-04-19 2012-08-08 Novartis AG Novel biomaterials, their preparation and use
JP4512700B2 (ja) * 2003-06-02 2010-07-28 トーアエイヨー株式会社 アシクロビル含有水溶液製剤
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
PT2116227E (pt) * 2003-06-13 2013-06-28 Novartis Ag Composições oftálmicas que contêm uma combinação sinérgica de dois polímeros
EP1741425B1 (en) * 2004-04-05 2008-05-28 Laboratorios Liomont, S.A. de C.V. Novel antiviral pharmaceutical composition
AU2005285040A1 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
IE51421B1 (en) 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
GB2217595B (en) 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
GB8919172D0 (en) 1989-08-23 1989-10-04 Univ Nottingham Useful composition
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679135B1 (fr) 1991-07-18 1995-05-19 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.
WO1993017664A1 (en) 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
SE9401108D0 (sv) 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
JPH08268892A (ja) * 1995-03-30 1996-10-15 Yuuwa Shoji:Kk 水溶液製剤及びその製造方法
GB2306885B (en) 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions
WO1998043643A1 (fr) 1997-04-01 1998-10-08 Toa Medicine Co., Ltd. Preparations d'une solution aqueuse d'acyclovir

Also Published As

Publication number Publication date
AU8878298A (en) 1999-03-22
GB9718568D0 (en) 1997-11-05
JPH11228386A (ja) 1999-08-24
EP1009380A1 (en) 2000-06-21
AU741609B2 (en) 2001-12-06
CA2301325A1 (en) 1999-03-11
DE69808938D1 (de) 2002-11-28
GB2328872B (en) 2002-04-03
GB9818973D0 (en) 1998-10-21
EP1009380B1 (en) 2002-10-23
US6379692B1 (en) 2002-04-30
ATE226428T1 (de) 2002-11-15
GB2328872A (en) 1999-03-10
ES2186207T3 (es) 2003-05-01
WO1999011239A1 (en) 1999-03-11
DE69808938T2 (de) 2003-07-03

Similar Documents

Publication Publication Date Title
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
FI950319A0 (fi) Säädellyn vapautumisnopeuden omaava morfiinivalmiste
DE69919713D1 (de) Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
BR0011772A (pt) Conjugado de droga-oligÈmero, composição farmacêutica, método de solubilização de uma droga em uma microemulsão, e, métodos para fornecer um conjugado de droga ativa - hidrófilo e um conjugado de droga ativa - peg a um sìtio de um indivìduo
HUP0004924A2 (hu) Ciklodextrineket tartalmazó gyógyászati készítmények
ATE204467T1 (de) Orale darreichungsform
ATE544447T1 (de) Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
HUP0002490A2 (hu) Csersav-polimer kompozíciók gyógyászati anyagok szabályozott leadására, különösen a szájüregben
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
IL92797A0 (en) Therapeutical active substituted benzimidazole and process for its preparation
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
ATE126052T1 (de) System zur gesteuerten freisetzung von wirkstoffen sowie verfahren zu dessen herstellung.
DK1146864T3 (da) pH-uafhængig farmaceutisk formulering med forlænget frisætning
DK0693926T3 (da) Ny farmaceutisk sammensætning til fremstilling af et stabilt pulver indeholdende en kombination af acetylsalicylsyre og metoclopramid som aktiv bestanddel.
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
ATE324103T1 (de) Arzneizubereitung mit kontrollierter freisetzung enthaltend tramadol hydrochlorid
EP0815851A3 (en) Method of reducing irritativeness of surface active agents and aqueous compositions with reduced irritativeness
KR910015297A (ko) 오메프라졸 경구용 약제와 그 제조방법